Physician

Alok Bansal, M.D.

According to 2025 Medicare claims, Alok Bansal, M.D. (NPI: 1568646776) practices ophthalmology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is NORTHERN CALIFORNIA RETINA VITREOUS ASSOCIATES MEDICAL GROUP, INC. (NPI: 1538275920; TIN: 942906234) and primary practice location at 95124-4002.

Bansal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 722 traditional Medicare patients, billed 12,614 HCPCS/CPT codes, and received $2,573,407 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 128 prescription claims across 44 beneficiaries totaling $8,846 in drug costs, led by Difluprednate (Difluprednate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,070,558 to $2,573,407. In contrast, Part D prescription costs have declined steadily, from $18,834 to $8,846. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.5M2015 Medicare payment: $1,070,558 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,706,352 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,237,792 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,674,096 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,473,049 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,937,295 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,494,672 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,382,341 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,017,822 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,573,407 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155796,736$1,070,558
20166248,733$1,706,352
20176829,707$2,237,792
201872710,707$2,674,096
201968510,632$2,473,049
202060212,860$2,937,295
202173414,118$3,494,672
202268313,107$3,382,341
202364114,019$3,017,822
202472212,614$2,573,407

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.4K$19K2015 Drug cost: $18,834 (USD; Tot_Drug_Cst)2016 Drug cost: $11,713 (USD; Tot_Drug_Cst)2017 Drug cost: $9,129 (USD; Tot_Drug_Cst)2018 Drug cost: $13,614 (USD; Tot_Drug_Cst)2019 Drug cost: $14,932 (USD; Tot_Drug_Cst)2020 Drug cost: $13,580 (USD; Tot_Drug_Cst)2021 Drug cost: $8,149 (USD; Tot_Drug_Cst)2022 Drug cost: $8,288 (USD; Tot_Drug_Cst)2023 Drug cost: $3,307 (USD; Tot_Drug_Cst)2024 Drug cost: $8,846 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201576254$18,834
201675203$11,713
201761143$9,129
201853196$13,614
201959180$14,932
202051193$13,580
202149125$8,149
202229110$8,288
20233676$3,307
202444128$8,846

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2252,781$658
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more257495$132
67028Injection of drug into eye2781,502$117
92012Established patient problem focused exam of visual system472958$89
92134Imaging of retina7022,426$41

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate18542$2,598
Prednisolone AcetatePrednisolone Acetate301,215$1,565
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha451,041$525
Ketorolac TromethamineKetorolac Tromethamine12465$322

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alok Bansal, M.D.?

Tedicare shows public-source Medicare data for Alok Bansal, M.D. (NPI 1568646776), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alok Bansal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alok Bansal, M.D.?

Alok Bansal, M.D. is linked to NORTHERN CALIFORNIA RETINA VITREOUS ASSOCIATES MEDICAL GROUP, INC. (billing NPI 1538275920) in the available physician profile data.

Does Alok Bansal, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.